Successful treatment of refractory hyperferritinemic syndromes with canakinumab: a report of two cases
Hyperferritinemic syndromes are systemic inflammatory disorders characterized by a dysfunctional immune response, which leads to excessive activation of the monocyte-macrophage system with hypercytokinemia and...
Source: Pediatric Rheumatology - Category: Rheumatology Authors: Riccardo Papa, Valentina Natoli, Roberta Caorsi, Francesca Minoia, Marco Gattorno and Angelo Ravelli Tags: Case Report Source Type: research
More News: Pediatrics | Rheumatology